Does SECUKINUMAB Cause Macular degeneration? 34 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Macular degeneration have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
34
Reports of Macular degeneration with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
1
Hospitalizations
How Dangerous Is Macular degeneration From SECUKINUMAB?
Of the 34 reports, 1 (2.9%) required hospitalization.
Is Macular degeneration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Macular degeneration?
ADALIMUMAB (1,407)
CARBOXYMETHYLCELLULOSE (828)
PREGABALIN (826)
PREDNISONE (821)
BUDESONIDE (820)
MESALAMINE (810)
METRONIDAZOLE (796)
ATORVASTATIN (794)
ACETAMINOPHEN (793)
ALPRAZOLAM (792)
Which SECUKINUMAB Alternatives Have Lower Macular degeneration Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG